跳至主要内容
临床试验/NCT02119039
NCT02119039已完成4 期

Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
40
试验地点
2
主要终点
Time to closure of the epithelial wound

研究概览

简要总结

CACICOL20 is an ophthalmic solution based on the technology of RGTAs (ReGeneraTingAgents). It consists of large biopolymers, imitating the structure of heparansulphate. The protecting effect on different biological tissues and enhancement of wound healing has been described in several studies.

Keratoconus is a relatively common disease, with incidences ranging from 1.3 to 25 per 100,000 per year across different populations. Corneal collagen cross-linking represents a treatment option for these patients, aiming to prevent progression of the disease via stabilization of corneal microstructure. Corneal epithelial removal prior to the ultraviolet A/riboflavin cross-linking procedure significantly improves the outcome of the intervention, due to ameliorated distribution of riboflavin.

The aim of the present study is to investigate the effect of CACICOL20 on corneal epithelial wound closure after collagen cross-linking in patients with keratoconus. Results may lead to an improved management and pain reduction of patients with corneal epithelial defects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged over 18 years
  • Presence of keratoconus
  • Scheduled for corneal cross linking
  • No ophthalmic surgery in the 3 months preceding the study

排除标准

  • Participation in a clinical trial in the previous 3 weeks
  • Topical use of aminoglycosid antibiotics
  • Use of therapeutic or refractive contact lenses after surgery
  • Known hypersensitivity to any component of the study medication or heparinoids or heparin
  • Active ocular infection
  • Presence of any abnormalities preventing reliable measurements as judged by the investigator
  • Pregnancy, planned pregnancy or lactating

结局指标

主要结局

Time to closure of the epithelial wound

时间窗: 5 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katarzyna J. Witkowska

MD, PhD

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验